このエントリーをはてなブックマークに追加
ID 65930
フルテキストURL
fulltext.pdf 1.19 MB
著者
Miyamoto, Kazuya Department of Gastroenterology and Hepatology, Okayama University Hospital
Matsumoto, Kazuyuki Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID publons
Obata, Taisuke Department of Gastroenterology and Hepatology, Okayama University Hospital
Sato, Ryosuke Department of Gastroenterology and Hepatology, Okayama University Hospital
Matsumi, Akihiro Department of Gastroenterology and Hepatology, Okayama University Hospital
Morimoto, Kosaku Department of Gastroenterology and Hepatology, Okayama University Hospital
Ogawa, Taiji Department of Gastroenterology and Hepatology, Okayama University Hospital
Terasawa, Hiroyuki Department of Gastroenterology and Hepatology, Okayama University Hospital
Fujii, Yuki Department of Gastroenterology and Hepatology, Okayama University Hospital
Yamazaki, Tatsuhiro Department of Gastroenterology and Hepatology, Okayama University Hospital
Uchida, Daisuke Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID researchmap
Horiguchi, Shigeru Department of Gastroenterology and Hepatology, Okayama University Hospital
Tsutsumi, Koichiro Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID researchmap
Kato, Hironari Department of Gastroenterology and Hepatology, Okayama University Hospital ORCID Kaken ID researchmap
Otsuka, Motoyuki Department of Gastroenterology and Hepatology, Okayama University Hospital
抄録
Background The sedation method used during double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) differs among countries and/or facilities, and there is no established method. This study aimed to evaluate the efficacy of non-anesthesiologist-administered propofol (NAAP) sedation using a target-controlled infusion (TCI) system during DB-ERCP.
Methods This retrospective study was conducted between May 2017 and December 2020 at an academic center. One hundred and fifty-six consecutive patients who underwent DB-ERCP were sedated by gastroenterologists using diazepam (n = 77) or propofol with a TCI system (n = 79), depending on the period. The primary endpoint was a comparison of poor sedation rates between the two groups. Poor sedation was defined as a condition requiring the use of other sedative agents or discontinuation of the procedure. Secondary endpoints were sedation-related adverse events and risk factors for poor sedation.
Results Poor sedation occurred significantly more often in the diazepam sedation group (diazepam sedation, n = 12 [16%] vs. propofol sedation, n = 1 [1%]; P = 0.001). Vigorous body movements (3 or 4) (diazepam sedation, n = 40 [52%] vs. propofol sedation, n = 28 [35%]; P = 0.038) and hypoxemia (< 85%) (diazepam sedation, n = 7 [9%] vs. propofol sedation, n = 1 [1%]; P = 0.027) occurred significantly more often in the diazepam sedation group. In the multivariate analysis, age < 70 years old (OR, 10.26; 95% CI, 1.57-66.98; P = 0.015), BMI = 25 kg/m2 (OR, 11.96; 95% CI, 1.67-85.69; P = 0.014), and propofol sedation (OR, 0.06; 95% CI, 0.01-0.58; P = 0.015) were associated factors for poor sedation.
Conclusions NAAP sedation with the TCI system during DB-ERCP was safer and more effective than diazepam sedation.
キーワード
Balloon-assisted endoscopy
Propofol
Diazepam
Sedation
備考
The version of record of this article, first published in BMC Gastroenterology, is available online at Publisher’s website: http://dx.doi.org/10.1186/s12876-023-02936-8
発行日
2023-09-04
出版物タイトル
BMC Gastroenterology
23巻
1号
出版者
BMC
開始ページ
296
ISSN
1471-230X
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© The Author(s) 2023.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1186/s12876-023-02936-8
ライセンス
http://creativecommons.org/licenses/by/4.0/
Citation
Miyamoto, K., Matsumoto, K., Obata, T. et al. The efficacy of non-anesthesiologist-administered propofol sedation with a target-controlled infusion system during double-balloon endoscopic retrograde cholangiopancreatography. BMC Gastroenterol 23, 296 (2023). https://doi.org/10.1186/s12876-023-02936-8
助成機関名
Japan Society for the Promotion of Science
助成番号
20K17050